Dr Reddy's Laboratories Ltd
The company, whose formulations include drugs for cardiovascular disorders, oncology and pain management, posted a net profit of Rs 574 crore compared with Rs 690 crore a year earlier.
It also said it bought the rights to sell the nicotine patch Habitrol in the United States from Novartis Consumer Health Inc, a unit of Swiss firm Novartis.
Dr Reddy's shares were down 2.5% at Rs 3,004 at 0657 GMT in Mumbai, while the Nifty was up 0.4%.
($1 = 61.3100 rupees)